Tyra Biosciences Inc TYRA

NAS: TYRA | ISIN: US90240B1061 16:18

18,05 USD (-1,15%)

(-1,15%) 16:18

Grafiek Tyra Biosciences Inc

Grafiek Tyra Biosciences Inc

1 dag1d -1,15%
1 week1w -2,43%
1 maand1m 16,45%
3 maanden3m -4,14%
6 maanden6m 60,16%
1 jaar1j 24,57%
5 jaar5j -30,58%

Tyra Biosciences Inc in het nieuws

Toon enkel gratis nieuws

9 mei 2024 · Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights · Persbericht

7 mei 2024 · Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors · Persbericht

19 maart 2024 · Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights · Persbericht

27 februari 2024 · Tyra Biosciences to Present at Upcoming Investor Conferences · Persbericht

7 februari 2024 · Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference · Persbericht

2 februari 2024 · Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing · Persbericht

1 februari 2024 · Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia · Persbericht

22 december 2023 · Tyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300 · Persbericht

8 november 2023 · Tyra Biosciences to Participate in 2023 Jefferies London Healthcare Conference · Persbericht

7 november 2023 · Tyra Biosciences Reports Third Quarter 2023 Financial Results and Highlights · Persbericht

Profiel Tyra Biosciences Inc

Werknemers: 34

Aandelen Tyra Biosciences Inc

Beurswaarde: 959,38 miljoen USD

Effecten: 52,54 miljoen

Beta: 1,81

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe